We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...
In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence found in previous ...
Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
H.C. Wainwright reaffirmed a Buy rating and a $14.00 price target on Evaxion Biotech (NASDAQ:EVAX), following the company's recent successful public offering. The stock currently trades at $2.45, down ...
Two Democratic senators on the committee that will get to decide whether to advance Robert F. Kennedy Jr.'s nomination say ...